UBS Maintains Neutral on GE HealthCare Techs, Lowers Price Target to $67

Benzinga Newsdesk www.benzinga.com Negative 85.8%

Neg 85.8% Neu 0% Pos 0%

UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and lowers the price target from $69 to $67.